news
Scmp World
2026-07-21
US biotech firm developing infant brain injury therapies eyes Hong Kong listing
A US-based biotech firm, Axiom Biosciences, is planning a primary listing in Hong Kong to raise at least $200 million. The company develops AI-powered therapies for severe infant brain injuries.